Effects of nicotine administration in a mouse model of familial hypertrophic cardiomyopathy, α-Tropomyosin D175N

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 301, Issue 4, 2011, Pages

  Gaffin, Robert D ^a   Chowdhury, Shamim A K ^a   Alves, Marco S L ^a,b   Dias, Fernando A L ^a,b   Ribeiro, Cibele T D ^a   Fogaca, Rosalvo T H ^b   Wieczorek, David F ^c   Wolska, Beata M ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Cardiac remodeling; In vivo pressure recordings; Phospholamban; Phosphorylation

Indexed keywords

ALPHA TROPOMYOSIN; NICOTINE TARTRATE; PHOSPHOLAMBAN; SERINE; THREONINE; TROPONIN I;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; FEMALE; HEART FUNCTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CELL; HEART MUSCLE RELAXATION; HEART RATE; MALE; MOUSE; MUTATION; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TRANSTHORACIC ECHOCARDIOGRAPHY; WESTERN BLOTTING;

ANIMALS; BLOOD PRESSURE; CALCIUM SIGNALING; CALCIUM-BINDING PROTEINS; CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; CELL SEPARATION; COLLAGEN; ECHOCARDIOGRAPHY; FEMALE; FLUORESCENT DYES; FURA-2; HEART RATE; HEMODYNAMICS; MALE; MICE; MYOCARDIAL CONTRACTION; MYOCARDIUM; MYOCYTES, CARDIAC; NICOTINE; NICOTINIC AGONISTS; TROPOMYOSIN; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 80053258372     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00277.2010     Document Type: Article

References (66)

1. Aberle NS, 2nd Privratsky JR, Burd L, Ren J. Combined acetaldehyde and nicotine exposure depresses cardiac contraction in ventricular myocytes: prevention by folic acid. Neurotoxicol Teratol 25: 731-736, 2003.
2. Ahmed SS, Moschos CB, Lyons MM, Oldewurtel HA, Coumbis RJ, Regan TJ. Cardiovascular effects of long-term cigarette smoking and nicotine administration. Am J Cardiol 37: 33-40, 1976.
3. Balakumar P, Kaur J. Is nicotine a key player or spectator in the induction and progression of cardiovascular disorders? Pharmacol Res 60: 361-368, 2009.
4. Barron KW, Heesch CM, Fleming BP, Chien CY, Diana JN. Effects of chronic smoke exposure on the cardiovascular responses to acute nicotine infusion in the rat. Eur J Pharmacol 146: 237-245, 1988.
5. Benowitz NL. Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment. Prog Cardiovasc Diseases 46: 91-111, 2003.
6. Benowitz NL. Pharmacology of nicotine: addiction and therapeutics. Annu Rev Pharmacol Toxicol 36: 597-613, 1996.
7. Benowitz NL. Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu Rev Pharmacol Toxicol 49: 57-71, 2009.
8. Benowitz NL, Kuyt F, Jacob P III. Circadian blood nicotine concentrations during cigarette smoking. Clin Pharmacol Ther 32: 758-764, 1982.
9. Bonne G, Carrier L, Richard P, Hainque B, Schwartz K. Familial hypertrophic cardiomyopathy: from mutations to functional defects. Circ Res 83: 580-593, 1998.
10. Burke AP, Farb A, Virmani R, Goodin J, Smialek JE. Sports-related and non-sports-related sudden cardiac death in young adults. Am Heart J 121: 568-575, 1991.
11. Castardeli E, Duarte DR, Minicucci MF, Azevedo PS, Matsubara BB, Matsubara LS, Campana AO, Paiva SA, Zornoff LA. Tobacco smokeinduced left ventricular remodelling is not associated with metalloproteinase-2 or -9 activation. Eur J Heart Fail 9: 1081-1085, 2007.
12. Castardeli E, Paiva SA, Matsubara BB, Matsubara LS, Minicucci MF, Azevedo PS, Campana AO, Zornoff LA. [Chronic cigarette smoke exposure results in cardiac remodeling and impaired ventricular function in rats]. Arq Bras Cardiol 84: 320-324, 2005.
13. Colyer J. Phosphorylation states of phospholamban. Ann NY Acad Sci 853: 79-91, 1998.
14. Dias FA, Walker LA, Arteaga GM, Walker JS, Vijayan K, Pena JR, Ke Y, Fogaca RT, Sanbe A, Robbins J, Wolska BM. The effect of myosin regulatory light chain phosphorylation on the frequency-dependent regulation of cardiac function. J Mol Cell Cardiol 41: 330-339, 2006.
15. Downey HF, Williams AG Jr, Yonekura S, Watanabe N, and Lawrence ME. Dominant role of circulating catecholamines in the myocardial contractile response to intravenous nicotine. J Cardiovasc Pharmacol 12: 58-64, 1988.
16. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kuhl U, Maisch B, McKenna WJ, Monserrat L, Pankuweit S, Rapezzi C, Seferovic P, Tavazzi L, Keren A. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 29: 270-276, 2008.
17. Evans CC, Pena JR, Phillips RM, Muthuchamy M, Wieczorek DF, Solaro RJ, Wolska BM. Altered hemodynamics in transgenic mice harboring mutant tropomyosin linked to hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol 279: H2414-H2423, 2000.
18. Fewell JE, Smith FG, Ng VK. Prenatal exposure to nicotine impairs protective responses of rat pups to hypoxia in an age-dependent manner. Respir Physiol 127: 61-73, 2001.
19. Fewell JE, Smith FG, Ng VK. Threshold levels of maternal nicotine impairing protective responses of newborn rats to intermittent hypoxia. J Appl Physiol 90: 1968-1976, 2001.
20. Folts JD, Bonebrake FC. The effects of cigarette smoke and nicotine on platelet thrombus formation in stenosed dog coronary arteries: inhibition with phentolamine. Circulation 65: 465-470, 1982.
21. Geisterfer-Lowrance AA, Christe M, Conner DA, Ingwall JS, Schoen FJ, Seidman CE, Seidman JG. A mouse model of familial hypertrophic cardiomyopathy. Science 272: 731-734, 1996.
22. Gu L, Pandey V, Geenen DL, Chowdhury SA, Piano MR. Cigarette smoke-induced left ventricular remodelling is associated with activation of mitogen-activated protein kinases. Eur J Heart Fail 10: 1057-1064, 2008.
23. Haass M, Kubler W. Nicotine and sympathetic neurotransmission. Cardiovasc Drugs Ther 10: 657-665, 1997.
24. Haggendal J, Henning M. Effect of chronically administered nicotine on axonal transport of dopamine-beta-hydroxylase in peripheral adrenergic neurons and on blood pressure and heart rate in the rat. Acta Physiol Scand Suppl 479: 35-38, 1980.
25. Hayashi H, Omichi C, Miyauchi Y, Mandel WJ, Lin SF, Chen PS, Karagueuzian HS. Age-related sensitivity to nicotine for inducible atrial tachycardia and atrial fibrillation. Am J Physiol Heart Circ Physiol 285: H2091-H2098, 2003.
26. Henningfield JE, Stapleton JM, Benowitz NL, Grayson RF, London ED. Higher levels of nicotine in arterial than in venous blood after cigarette smoking. Drug Alcohol Depend 33: 23-29, 1993.
27. Holtz J, Sommer O, Bassenge E. Development of specific tolerance to nicotine infusions in dogs on chronic nicotine treatment. Klin Wochenschr 62, Suppl 2: 51-57, 1984.
28. Ikeda Y, Hoshijima M, Chien KR. Toward biologically targeted therapy of calcium cycling defects in heart failure. Physiology 23: 6-16, 2008.
29. Isaac PF, Rand MJ. Blood levels of nicotine and physiological effects after inhalation of tobacco smoke. Eur J Pharmacol 8: 269-283, 1969.
30. Kobayashi T, Yang X, Walker LA, Van Breemen RB, Solaro RJ. A non-equilibrium isoelectric focusing method to determine states of phosphorylation of cardiac troponin I: identification of Ser-23 and Ser-24 as significant sites of phosphorylation by protein kinase C. J Mol Cell Cardiol 38: 213-218, 2005.
31. Kranias EG, Solaro RJ. Phosphorylation of troponin I and phospholamban during catecholamine stimulation of rabbit heart. Nature 298: 182-184, 1982.
32. Liberthson RR. Sudden death from cardiac causes in children and young adults. N Engl J Med 334: 1039-1044, 1996.
33. MacDougall LK, Jones LR, Cohen P. Identification of the major protein phosphatases in mammalian cardiac muscle which dephosphorylate phospholamban. Eur J Biochem 196: 725-734, 1991.
34. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 287: 1308-1320, 2002.
35. Maron BJ, Thompson PD, Puffer JC, McGrew CA, Strong WB, Douglas PS, Clark LT, Mitten MJ, Crawford MH, Atkins DL, Driscoll DJ, Epstein AE. Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association. Circulation 94: 850-856, 1996.
36. Means AR. Regulatory cascades involving calmodulin-dependent protein kinases. Mol Endocrinol 14: 4-13, 2000.
37. Mehta MC, Jain AC, Billie M. Combined effects of alcohol and nicotine on cardiovascular performance in a canine model. J Cardiovasc Pharmacol 31: 930-936, 1998.
38. Mehta MC, Jain AC, Billie MD. Combined effects of cocaine and nicotine on cardiovascular performance in a canine model. Clin Cardiol 24: 620-626, 2001.
39. Mehta MC, Jain AC, Mehta A, Billie M. Cardiac arrhythmias following intravenous nicotine: experimental study in dogs. J Cardiovasc Pharmacol Ther 2: 291-298, 1997.
40. Metzger JM, Westfall MV. Covalent and noncovalent modification of thin filament action: the essential role of troponin in cardiac muscle regulation. Circ Res 94: 146-158, 2004.
41. Miyauchi M, Qu Z, Miyauchi Y, Zhou SM, Pak H, Mandel WJ, Fishbein MC, Chen PS, Karagueuzian HS. Chronic nicotine in hearts with healed ventricular myocardial infarction promotes atrial flutter that resembles typical human atrial flutter. Am J Physiol Heart Circ Physiol 288: H2878-H2886, 2005.
42. Muthuchamy M, Pieples K, Rethinasamy P, Hoit B, Grupp IL, Boivin GP, Wolska B, Evans C, Solaro RJ, Wieczorek DF. Mouse model of a familial hypertrophic cardiomyopathy mutation in alpha- tropomyosin manifests cardiac dysfunction. Circ Res 85: 47-56, 1999.
43. Nakajima-Taniguchi C, Matsui H, Nagata S, Kishimoto T, Yamauchi-Takihara K. Novel missense mutation in alpha-tropomyosin gene found in Japanese patients with hypertrophic cardiomyopathy. J Mol Cell Cardiol 27: 2053-2058, 1995.
44. Pena JR, Szkudlarek AC, Warren CM, Heinrich LS, Gaffin RD, Jagatheesan G, Del Monte F, Hajjar RJ, Goldspink PH, Solaro RJ, Wieczorek DF, Wolska BM. Neonatal gene transfer of Serca2a delays onset of hypertrophic remodeling and improves function in familial hypertrophic cardiomyopathy. J Mol Cell Cardiol 49: 993-1002, 2010.
45. Pena JR, Wolska BM. Troponin I phosphorylation plays an important role in the relaxant effect of beta-adrenergic stimulation in mouse hearts. Cardiovasc Res 61: 756-763, 2004.
46. Piano MR, Benowitz NL, Fitzgerald GA, Corbridge S, Heath J, Hahn E, Pechacek TF, Howard G. Impact of smokeless tobacco products on cardiovascular disease: implications for policy, prevention, and treatment: a policy statement from the American Heart Association. Circulation 122: 1520-1544.
47. Przyklenk K. Nicotine exacerbates postischemic contractile dysfunction of "stunned " myocardium in the canine model. Possible role of free radicals. Circulation 89: 1272-1281, 1994.
48. Rajan S, Jagatheesan G, Karam CN, Alves ML, Bodi I, Schwartz A, Bulcao CF, D'Souza KM, Akhter SA, Boivin GP, Dube DK, Petrashevskaya N, Herr AB, Hullin R, Liggett SB, Wolska BM, Solaro RJ, Wieczorek DF. Molecular and functional characterization of a novel cardiac-specific human tropomyosin isoform. Circulation 121: 410-418, 2010.
49. Richardson D, Morton R, Howard J. Effects of chronic nicotine administration on RBC velocity in mesenteric capillaries of the rat. Blood Vessels 14: 318-324, 1977.
50. Richardson DR, Morton RF. Differential effects of chronic nicotine and tobacco smoke administration on iliac vascular resistance in the rat. Proc Soc Exp Biol Med 161: 386-390, 1979.
51. Satoh H. Modulation by nicotine of the ionic currents in guinea pig ventricular cardiomyocytes. Relatively higher sensitivity to IKr and IKl. Vascul Pharmacol 39: 55-61, 2002.
52. Schievelbein H, Eberhardt R. Cardiovascular actions of nicotine and smoking. J Natl Cancer Inst 48: 1785-1794, 1972.
53. Stojanovic MO, Ziolo MT, Wahler GM, Wolska BM. Anti-adrenergic effects of nitric oxide donor SIN-1 in rat cardiac myocytes. Am J Physiol Cell Physiol 281: C342-C349, 2001.
54. Thierfelder L, Watkins H, MacRae C, Lamas R, McKenna W, Vosberg HP, Seidman JG, Seidman CE. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 77: 701-712, 1994.
55. Turner DM. Metabolism of small multiple doses of (14C) nicotine in the cat. Br J Pharmacol 41: 521-529, 1971.
56. Urboniene D, Dias FA, Pena JR, Walker LA, Solaro RJ, Wolska BM. Expression of slow skeletal troponin I in adult mouse heart helps to maintain the left ventricular systolic function during respiratory hypercapnia. Circ Res 97: 70-77, 2005.
57. Wang H, Shi H, Zhang L, Pourrier M, Yang B, Nattel S, Wang Z. Nicotine is a potent blocker of the cardiac A-type K(+) channels. Effects on cloned Kv43 channels and native transient outward current. Circulation 102: 1165-1171, 2000.
58. Wenzel DG, Azmeh N. Chronically administered nicotine and the blood pressure of normotensive and renal hypertensive rats. Arch Int Pharmacodyn Ther 187: 367-376, 1970.
59. Wolska BM, Arteaga GM, Pena JR, Nowak G, Phillips RM, Sahai S, de Tombe PP, Martin AF, Kranias EG, Solaro RJ. Expression of slow skeletal troponin I in hearts of phospholamban knockout mice alters the relaxant effect of beta-adrenergic stimulation. Circ Res 90: 882-888, 2002.
60. 2+ and altered dynamics of contraction and relaxation in transgenic cardiac cells that express beta-tropomyosin. Circ Res 84: 745-751, 1999.
61. Wolska BM, Kitada Y, Palmiter KA, Westfall MV, Johnson MD, Solaro RJ. CGP-48506 increases contractility of ventricular myocytes and myofilaments by effects on actin-myosin reaction. Am J Physiol Heart Circ Physiol 270: H24-H32, 1996.
62. Wolska BM, Solaro RJ. Method for isolation of adult mouse cardiac myocytes for studies of contraction and microfluorimetry. Am J Physiol Heart Circ Physiol 271: H1250-H1255, 1996.
63. 2+. Am J Physiol Cell Physiol 271: C391-C397, 1996.
64. Yang Q, Sanbe A, Osinska H, Hewett TE, Klevitsky R, Robbins J. A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy. J Clin Invest 102: 1292-1300, 1998.
65. Yashima M, Ohara T, Cao JM, Kim YH, Fishbein MC, Mandel WJ, Chen PS, Karagueuzian HS. Nicotine increases ventricular vulnerability to fibrillation in hearts with healed myocardial infarction. Am J Physiol Heart Circ Physiol 278: H2124-H2133, 2000.
66. 2+ affinity of cardiac troponin C. J Biol Chem 270: 30773-30780, 1995.